Pityriasis rubra pilaris type IV-associated arthritis treated with adalimumab

DOĞAN Y.

International Journal of Rheumatic Diseases, cilt.26, sa.6, ss.1157-1161, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 6
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1111/1756-185x.14597
  • Dergi Adı: International Journal of Rheumatic Diseases
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1157-1161
  • Anahtar Kelimeler: circumscribed juvenile form, dactylitis, psoriasis, synovitis, TNF alpha inhibitors
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

© 2023 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.Pityriasis rubra pilaris (PRP) is a very rare disease from the hyperkeratotic papulosquamous disorder group. The rheumatologic manifestations of PRP are extremely rare and less known to clinicians than those of psoriasis. An interesting case of inflammatory arthritis in the hand of an adolescent patient who was successfully treated with adalimumab and compatible with the diagnosis of type IV circumscribed juvenile PRP is presented in the light of the literature.